DROSPIRENON/ETHINYLESTRADIOL WH-PHARMA
3MG/0,02MG TBL FLM 3X28(21+7)
| SÚKL code | 0220761 |
|---|---|
| Name of the product | DROSPIRENON/ETHINYLESTRADIOL WH-PHARMA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | DROSPIRENON/ETHINYLESTRADIOL WH-PHARMA |
| Supplement | 3MG/0,02MG TBL FLM 3X28(21+7) |
| Strenght | 3MG/0,02MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 3X28(21+7) |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance |
ETHINYLESTRADIOL (ETHINYLESTRADIOLUM) DROSPIRENONE (DROSPIRENONUM) |
| ATC group | G03AA12 |
| ATC group name | DROSPIRENON A ETHINYLESTRADIOL |
Marketing authorisation information
| Registration Number | 17/1046/16-C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 01. 2020 |
| MA Holder | WH-Pharma s.r.o., Kutná Hora |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | Aristo Pharma GmbH, Berlin |
| Actual MA holder country | NĚMECKO |
cz